MyFinsight
Home
Blog
About
Back
Income Statement
SUTRO BIOPHARMA, INC. (STRO)
SUTRO BIOPHARMA, INC. (STRO)
source: myfinsight.com
Net loss
-$38,533K
(-235.10%↓ Y/Y)
Loss before
provision for income taxes
-$38,532K
(-234.57%↓ Y/Y)
Provision for / (benefit)
from income taxes
$1K
(105.56%↑ Y/Y)
Interest income
$1,723K
(-31.60%↓ Y/Y)
Astellas Pharma Inc
Astellas
$9,637K
Vaxcyte Inc
$177K
Other
$25K
Loss from operations
-$29,888K
(-793.51%↓ Y/Y)
Non-cash interest
expense related to the...
$9,862K
(2.23%↑ Y/Y)
Revenue
$9,839K
(-84.57%↓ Y/Y)
Interest and other income
(expense), net
-$505K
(51.63%↑ Y/Y)
Total operating
expenses
$39,727K
(-40.79%↓ Y/Y)
Research and development
$31,695K
(-17.30%↓ Y/Y)
General and
administrative
$7,831K
(-24.29%↓ Y/Y)
Restructuring and related
costs
$201K
(-98.91%↓ Y/Y)
Back